Empowering Teams,

Transforming Therapeutics

Talem Therapeutics (Talem) is a wholly owned subsidiary of ImmunoPrecise Antibodies (IPA) and is focused on the discovery and development of next-generation, fully human, monoclonal, therapeutic antibodies to target multiple disease indications.


Using the proprietary antibody discovery platforms and innovative technologies housed at ImmunoPrecise Antibodies and U-Protein Express (an IPA company), Talem aims to accelerate novel, high-value, therapeutic antibody treatments to the clinic.

Privacy policy

© 2017 All Rights Reserved